A small protein involved in neurodegeneration leading to Parkinson’s disease also drives a type of skin cancer known as melanoma, new research led by Oregon Health & Science University finds.
The study, published today in the journal Science Advances, suggests new avenues for drug development to reduce the risk of developing both Parkinson’s and skin cancer by targeting the alpha-synuclein protein, which appears to have a critical role in regulating cellular functions.
“Developing drugs that…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply